Khondrion's sonlicromanol faces setback in phase 2 trial, but holds onto hope
FierceBiotech - 22-Nov-2024Long-term follow-up data and post-hoc analyses fuel optimism for treating mitochondrial diseases
Join the club for FREE to access the whole archive and other member benefits.
Long-term follow-up data and post-hoc analyses fuel optimism for treating mitochondrial diseases
FAB1 compound reduces ageing markers in cells while FAB15 accelerates wound healing
This innovation aims to make managing diabetes and improve patients' quality of life
Approach is based on research from UCSF and could transform how diseases are treated
Small molecule unlocks youthful telomerase, reversing age-related decline in mice
Click on resource name for more details.
No blog posts found!